Skip to main content

Table 2 Preprocedural and postprocedural echocardiography data, Intraprocedural information

From: Repeat transcatheter aortic valve implantation using a latest generation balloon-expandable device for treatment of failing transcatheter heart valves

 

Patient no. 1

Patient no. 2

Patient no. 3

TTE/TEE before 2nd procedure

   

 LVEF (%)

60

50

30

 Gradient max/mean (mm Hg)

18/9

24/12

15/12

 EOA (cm2)

1.7

2.2

2.3

 Valve insufficiency

severe

moderate-severe

severe

 ViV procedure

Edwards Sapien XT

JenaValve

CoreValve

 Edwards Sapien 3 size (mm)

26

29

29

 Procedure time (mm)

95

100

180

 Fluoroscopy time (min)

10

11

20

 Contrast agent (mL)

121

125

174

TTE discharge

   

 LVEF (%)

60

50

30

 EOA (cm2)

1.5

2.5

2.5

 Gradient max/mean (mm Hg)

36/16

17/9

14/6

 Paravalvular leakage

none

trace

trace

ICU stay (d)

2

1

1

Hospital stay (d)

10

8

20

VARC-2 events at 30 days

Major bleeding

None

TIA

  1. TTE transthoracic echocardiography; TEE transesophageal echocardiography; LVEF left ventricular ejection fraction; ViV valve-in-valve; mm millimeter; min minutes; mL milliliter; EOA effective orifice area; ICU intensive care unit; VARC-2 Valve academic research consortium; TIA transitory ischemic attack; SD standard deviation